Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Observational Study of Pediatric Patients With Neuronopathic Forms of MPS II (Hunter Syndrome)

NCT04591834 is registered in ClinicalTrials.gov with REGENXBIO Inc. as lead sponsor.

NCT NCT04591834
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04591834 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Observational Study of Pediatric Patients With Neuronopathic Forms of MPS II (Hunter Syndrome)
Lead sponsor
REGENXBIO Inc.
Phase
Observational
Overall status
Withdrawn
Start date
March 31, 2022
Completion date
July 31, 2025
Enrollment
0 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

mucopolysaccharidosis ii